CIK 0001599298 · Large accelerated filer
Summit Therapeutics Inc.
Sign in to watch- Ticker
- SMMT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 371979717
- Phone
- 305-203-2034
- Business address
- 601 BRICKELL KEY DRIVE, SUITE 1000, MIAMI, FL, 33131
- Former names
- Summit Therapeutics plc, Summit Corp plc
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 8 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-04-29 | Soni Manmeet Singh COO and CFO | Grant or award · Stock Option (right to buy) | +11,200,000 | 11,200,000 | ||
| 2025-04-29 | DUGGAN ROBERT W Co-Chief Executive Officer | Grant or award · Stock Option (right to buy) | +1,040,000 | 1,040,000 | ||
| 2025-04-29 | DUGGAN ROBERT W Co-Chief Executive Officer | Grant or award · Stock Option (right to buy) | +400,000 | 400,000 | ||
| 2025-04-29 | DUGGAN ROBERT W Co-Chief Executive Officer | Grant or award · Stock Option (right to buy) | +9,590,558 | 9,590,558 | ||
| 2025-04-29 | Zanganeh Mahkam Co-Chief Executive Officer | Grant or award · Stock Option (right to buy) | +1,040,000 | 1,040,000 | ||
| 2025-04-29 | Zanganeh Mahkam Co-Chief Executive Officer | Grant or award · Stock Option (right to buy) | +400,000 | 400,000 | ||
| 2025-04-29 | Zanganeh Mahkam Co-Chief Executive Officer | Grant or award · Stock Option (right to buy) | +9,590,558 | 9,590,558 | ||
| 2025-04-08 | Zanganeh Mahkam Co-Chief Executive Officer | Option exercise | +3,985,055 | $1.58 | $6.3M | 555,680,151 |
| 2025-04-08 | Zanganeh Mahkam Co-Chief Executive Officer | Option exercise · Warrant (right to buy) | +3,985,055 | 0 | ||
| 2025-04-08 | DUGGAN ROBERT W Co-Chief Executive Officer | Option exercise | +3,985,055 | $1.58 | $6.3M | 555,680,151 |
| 2025-04-08 | DUGGAN ROBERT W Co-Chief Executive Officer | Option exercise · Warrant (right to buy) | +3,985,055 | 0 | ||
| 2025-01-12 | Anand Bhaskar Chief Accounting Officer | Grant or award · Stock Option (right to buy) | +75,000 | 75,000 | ||
| 2025-01-02 | DUGGAN ROBERT W Co-Chief Executive Officer | Grant or award · Stock Option (right to buy) | +10,724 | $9.18 | $98K | 10,724 |
| 2025-01-02 | Zanganeh Mahkam Co-Chief Executive Officer | Grant or award · Stock Option (right to buy) | +10,724 | $9.18 | $98K | 10,724 |
| 2025-01-02 | Huber Jeff Director | Grant or award · Stock Option (right to buy) | +35,000 | 35,000 | ||
| 2025-01-02 | Xia Yu Director | Grant or award · Stock Option (right to buy) | +35,000 | 35,000 | ||
| 2025-01-02 | Xia Yu Director | Grant or award · Stock Option (right to buy) | +5,438 | $9.18 | $50K | 5,438 |
| 2025-01-02 | Cesano Alessandra Director | Grant or award · Stock Option (right to buy) | +35,000 | 35,000 | ||
| 2025-01-02 | Cesano Alessandra Director | Grant or award · Stock Option (right to buy) | +3,073 | $9.18 | $28K | 3,073 |
| 2025-01-02 | Ronaghi Mostafa Director | Grant or award · Stock Option (right to buy) | +35,000 | 35,000 |
Page 3 of 9 · 163 trades